These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 22440733)

  • 1. Overexpression of nuclear NHERF1 in advanced colorectal cancer: association with hypoxic microenvironment and tumor invasive phenotype.
    Malfettone A; Silvestris N; Paradiso A; Mattioli E; Simone G; Mangia A
    Exp Mol Pathol; 2012 Jun; 92(3):296-303. PubMed ID: 22440733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of trefoil factors and TWIST1 in colorectal cancer and their correlation with metastatic potential and prognosis.
    Yusup A; Huji B; Fang C; Wang F; Dadihan T; Wang HJ; Upur H
    World J Gastroenterol; 2017 Jan; 23(1):110-120. PubMed ID: 28104986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presence of Twist1-positive neoplastic cells in the stroma of chromosome-unstable colorectal tumors.
    Celesti G; Di Caro G; Bianchi P; Grizzi F; Basso G; Marchesi F; Doni A; Marra G; Roncalli M; Mantovani A; Malesci A; Laghi L
    Gastroenterology; 2013 Sep; 145(3):647-57.e15. PubMed ID: 23684708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of hypoxia-inducible factor-1alpha, TWIST1 and Snail expression in resectable non-small cell lung cancer.
    Hung JJ; Yang MH; Hsu HS; Hsu WH; Liu JS; Wu KJ
    Thorax; 2009 Dec; 64(12):1082-9. PubMed ID: 19778933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of nuclear NHERF1 in colorectal cancer progression.
    Mangia A; Saponaro C; Malfettone A; Bisceglie D; Bellizzi A; Asselti M; Popescu O; Reshkin SJ; Paradiso A; Simone G
    Oncol Rep; 2012 Sep; 28(3):889-94. PubMed ID: 22766563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of hypoxia inducible factor-1 alpha is an independent risk factor for recurrence after curative resection of colorectal liver metastases.
    Shimomura M; Hinoi T; Kuroda S; Adachi T; Kawaguchi Y; Sasada T; Takakura Y; Egi H; Okajima M; Tashiro H; Nishizaka T; Ohdan H
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S527-36. PubMed ID: 23748663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peritumoral vascular invasion and NHERF1 expression define an immunophenotype of grade 2 invasive breast cancer associated with poor prognosis.
    Malfettone A; Saponaro C; Paradiso A; Simone G; Mangia A
    BMC Cancer; 2012 Mar; 12():106. PubMed ID: 22439624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NHERF1 and tumor microenvironment: a new scene in invasive breast carcinoma.
    Saponaro C; Vagheggini A; Scarpi E; Centonze M; Catacchio I; Popescu O; Pastena MI; Giotta F; Silvestris N; Mangia A
    J Exp Clin Cancer Res; 2018 May; 37(1):96. PubMed ID: 29716631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia-inducible factor-1alpha modulates the down-regulation of the homeodomain protein CDX2 in colorectal cancer.
    Zheng J; Sun X; Wang W; Lu S
    Oncol Rep; 2010 Jul; 24(1):97-104. PubMed ID: 20514449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potential predictive role of nuclear NHERF1 expression in advanced gastric cancer patients treated with epirubicin/oxaliplatin/capecitabine first line chemotherapy.
    Mangia A; Caldarola L; Dell'Endice S; Scarpi E; Saragoni L; Monti M; Santini D; Brunetti O; Simone G; Silvestris N
    Cancer Biol Ther; 2015; 16(8):1140-7. PubMed ID: 26126066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Semaphorin 4D and hypoxia-inducible factor-1α overexpression is related to prognosis in colorectal carcinoma.
    Wang JS; Jing CQ; Shan KS; Chen YZ; Guo XB; Cao ZX; Mu LJ; Peng LP; Zhou ML; Li LP
    World J Gastroenterol; 2015 Feb; 21(7):2191-8. PubMed ID: 25717256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia-inducible factor 1 alpha expression increases during colorectal carcinogenesis and tumor progression.
    Simiantonaki N; Taxeidis M; Jayasinghe C; Kurzik-Dumke U; Kirkpatrick CJ
    BMC Cancer; 2008 Nov; 8():320. PubMed ID: 18983642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TWIST1 and SNAI1 as markers of poor prognosis in human colorectal cancer are associated with the expression of ALDH1 and TGF-β1.
    Kim YH; Kim G; Kwon CI; Kim JW; Park PW; Hahm KB
    Oncol Rep; 2014 Mar; 31(3):1380-8. PubMed ID: 24402192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of EGFR, Her2 predict lymph node metastasis (LNM)-associated metastasis in colorectal cancer.
    Lu Y; Jingyan G; Baorong S; Peng J; Xu Y; Cai S
    Cancer Biomark; 2012; 11(5):219-26. PubMed ID: 23220854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombin induces expression of twist and cell motility via the hypoxia-inducible factor-1α translational pathway in colorectal cancer cells.
    Chang LH; Chen CH; Huang DY; Pai HC; Pan SL; Teng CM
    J Cell Physiol; 2011 Apr; 226(4):1060-8. PubMed ID: 20857420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. β-catenin interaction with NHERF1 and RASSF1A methylation in metastatic colorectal cancer patients.
    Schirosi L; Mazzotta A; Opinto G; Pinto R; Graziano G; Tommasi S; Fucci L; Simone G; Mangia A
    Oncotarget; 2016 Oct; 7(42):67841-67850. PubMed ID: 27765918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression patterns of hypoxic markers at the invasive margin of colorectal cancers and liver metastases.
    Rajaganeshan R; Prasad R; Guillou PJ; Scott N; Poston G; Jayne DG
    Eur J Surg Oncol; 2009 Dec; 35(12):1286-94. PubMed ID: 19540709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A ROS/STAT3/HIF-1α signaling cascade mediates EGF-induced TWIST1 expression and prostate cancer cell invasion.
    Cho KH; Choi MJ; Jeong KJ; Kim JJ; Hwang MH; Shin SC; Park CG; Lee HY
    Prostate; 2014 May; 74(5):528-36. PubMed ID: 24435707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TWIST1 and TWIST2 promoter methylation and protein expression in tumor stroma influence the epithelial-mesenchymal transition-like tumor budding phenotype in colorectal cancer.
    Galván JA; Helbling M; Koelzer VH; Tschan MP; Berger MD; Hädrich M; Schnüriger B; Karamitopoulou E; Dawson H; Inderbitzin D; Lugli A; Zlobec I
    Oncotarget; 2015 Jan; 6(2):874-85. PubMed ID: 25528769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of SATB1 as a Specific Biomarker for Lymph Node Metastasis in Colorectal Cancer.
    Baba H; Ishikawa T; Mogushi K; Ishiguro M; Uetake H; Tanaka H; Sugihara K
    Anticancer Res; 2016 Aug; 36(8):4069-76. PubMed ID: 27466515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.